{"id":"W2804336813","doi":"10.1136/jnnp-2018-anzan.60","title":"061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE)","year":2018,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Ocrelizumab; Expanded Disability Status Scale; Medicine; Multiple sclerosis; Internal medicine; Interferon beta-1a; Oncology; Interferon beta; Gastroenterology; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004931156,0.0003110018,0.0008117558,0.0002894738,0.0001232041,0.00001745723,0.0002091875,0.0002174639,0.00003998888],"category_scores_gemma":[0.0005014116,0.0002293698,0.0002741171,0.0005311609,0.0007067743,0.0003487166,0.00009019049,0.001101831,0.000001804636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003833199,"about_ca_system_score_gemma":0.0002522228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002038273,"about_ca_topic_score_gemma":0.00007280263,"domain_scores_codex":[0.9968548,0.000463864,0.001058607,0.0004852192,0.0006969357,0.0004405073],"domain_scores_gemma":[0.9975516,0.0002336249,0.001215604,0.0004588876,0.0003078733,0.0002324129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02735235,0.003349165,0.954295,0.00007215634,0.00003176924,0.0000680378,0.00008953961,0.00002820016,0.008351465,0.000001804357,0.0009156222,0.005444939],"study_design_scores_gemma":[0.005324546,0.008955783,0.9835986,0.0003649601,0.00006691173,0.0001587688,0.00003130291,0.00006933772,0.001032934,0.00004281856,0.0001882776,0.0001656993],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932167,0.0001540195,0.00001498626,0.002650323,0.003497103,0.0003531863,0.000007097582,0.00002407087,0.00008252651],"genre_scores_gemma":[0.9982957,0.0001160055,0.0002675187,0.001009713,0.0002479093,0.000004351305,0.000001801323,0.00004999165,0.000007004347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02930371,"threshold_uncertainty_score":0.9353431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01607467090997377,"score_gpt":0.253577009761121,"score_spread":0.2375023388511472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}